Immune-Onc Therapeutics Funding: $110M Raised, Series B

Immune-Onc Therapeutics funding overview

Immune-Onc Therapeutics is based in Palo Alto. Immune-Onc Therapeutics has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Immune-Onc Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Fame Mount Limited, CLI Ventures, Oceanpine Capital, Octagon Capital, Sphera Healthcare, Northern Light Venture Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Immune-Onc Therapeutics at a glance

Total raised: $110M
Latest round: Series B
Latest round date: January 2023
Headquarters: Palo Alto
Notable investors: Fame Mount Limited, CLI Ventures, Oceanpine Capital, Octagon Capital, Sphera Healthcare, Northern Light Venture Capital, Vivo Capital, The Leukemia & Lymphoma Society's Therapy Acceleration Prog…

Frequently asked about Immune-Onc Therapeutics funding

How much has Immune-Onc Therapeutics raised?: Immune-Onc Therapeutics has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Immune-Onc Therapeutics?: Fame Mount Limited, CLI Ventures, Oceanpine Capital, Octagon Capital, Sphera Healthcare, Northern Light Venture Capital are named among the investors backing Immune-Onc Therapeutics.
What was the latest Immune-Onc Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2023.
Where is Immune-Onc Therapeutics based?: Immune-Onc Therapeutics is based in Palo Alto.
When did Immune-Onc Therapeutics last raise?: The last disclosed Immune-Onc Therapeutics round closed in January 2023 at Series B.

We update the Immune-Onc Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Palo Alto and their backers are listed below.

Immune-Onc Therapeutics Funding: $110M Raised, Series B

Immune-Onc Therapeutics funding overview

Immune-Onc Therapeutics at a glance

Frequently asked about Immune-Onc Therapeutics funding

Companies related to Immune-Onc Therapeutics (18)

Browse related funding lists (8)